Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 74,274 | 58,301 | 57,584 | 49,504 | 39,503 |
| Cost of Goods | 15,096 | 11,996 | 7,647 | 6,190 | 5,038 |
| Gross Profit | 59,178 | 46,305 | 49,937 | 43,314 | 34,465 |
| Operating Expenses | 63,239 | 62,778 | 56,512 | 58,775 | 94,427 |
| Operating Income | -3,965 | -15,477 | -5,928 | -15,271 | -59,924 |
| Interest Expense | 15,103 | 15,797 | 16,418 | 16,108 | 17,518 |
| Other Income | 1,486 | 905 | 1,198 | 1,406 | 1,632 |
| Pre-tax Income | -17,582 | -30,369 | -21,148 | -29,973 | -75,810 |
| Net Income Continuous | -17,582 | -30,369 | -21,148 | -29,973 | -75,810 |
| Net Income | $-17,582 | $-30,369 | $-21,148 | $-29,973 | $-75,810 |
| EPS Basic Total Ops | -0.21 | -0.37 | -0.26 | -0.41 | -1.05 |
| EPS Basic Continuous Ops | -0.21 | -0.37 | -0.27 | -0.41 | -1.05 |
| EPS Diluted Total Ops | -0.21 | -0.37 | -0.26 | -0.41 | -1.05 |
| EPS Diluted Continuous Ops | -0.21 | -0.37 | -0.27 | -0.41 | -1.05 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.25 | -0.16 | -0.28 | -0.90 |
| EBITDA(a) | $-2,939 | $-14,523 | $-4,991 | $-14,340 | $-59,018 |